UNITED GUARDIAN INC — Form 8-K
Filed August 7, 2026 · analyzed by the 8-K Agent
8-K
▲ Likely positive
significance 48/100
What the filing says
Q2 2026: net sales $3.1M (+10% YoY), net income $728.6K (+16% YoY), EPS $0.16 (+14% YoY). H1 2026: net sales $6.0M (+12% YoY), net income $1.55M (+30% YoY), EPS $0.34 (+31% YoY). Cosmetic ingredient sales surged 44% Q2 (34% H1) driven by Ashland Specialty Ingredients normalizing inventory; pharmaceutical sales grew 1% Q2 (11% H1), led by Renacidin. One-time settlement income of $339.5K H1 boosted results.
Why this rating
Organic sales growth of ~10-12% and net income growth of 16-30% is solid for a micro-cap, but one-time settlement income ($339.5K, 9.2% of H1 net income) inflates bottom-line results. Cosmetic ingredient surge tied to distributor inventory normalization, not structural demand shift. Results are tangible good news but not transformational relative to $36.8M market cap.
See more from August 7, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.